![Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00125-022-05787-2/MediaObjects/125_2022_5787_Fig4_HTML.png)
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia
![Deviations from the ADA/EASD treatment algorithm is associated with higher cardiovascular events and death in type 2 diabetes under routine care - Media Centre | EASD Deviations from the ADA/EASD treatment algorithm is associated with higher cardiovascular events and death in type 2 diabetes under routine care - Media Centre | EASD](https://d2t0unnjxes6lt.cloudfront.net/data/easd/data/talks/1167_879989/Slide2.jpg)
Deviations from the ADA/EASD treatment algorithm is associated with higher cardiovascular events and death in type 2 diabetes under routine care - Media Centre | EASD
![Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00125-022-05787-2/MediaObjects/125_2022_5787_Fig5_HTML.png)
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia
![Consenso ADA-EASD tratamiento diabetes tipo 2, resultados del estudio TANDEM, y más… | Servicio de Medicina Interna del Hospital de León Consenso ADA-EASD tratamiento diabetes tipo 2, resultados del estudio TANDEM, y más… | Servicio de Medicina Interna del Hospital de León](https://mileon.files.wordpress.com/2018/10/47c7908f410a4c7b8f3a344eff4058f1_m.jpg)
Consenso ADA-EASD tratamiento diabetes tipo 2, resultados del estudio TANDEM, y más… | Servicio de Medicina Interna del Hospital de León
![ADA/EASD consensus update on management of hyperglycaemia in type 2 diabetes – report published in Diabetologia and Diabetes Care – Diabetologia ADA/EASD consensus update on management of hyperglycaemia in type 2 diabetes – report published in Diabetologia and Diabetes Care – Diabetologia](https://diabetologia-journal.org/wp-content/uploads/2022/09/Screenshot-2022-09-21-at-13.20.37.png)
ADA/EASD consensus update on management of hyperglycaemia in type 2 diabetes – report published in Diabetologia and Diabetes Care – Diabetologia
![Management Diabetes mellitus Typ 1 – Consensus Report von ADA/EASD - Diabetologie & Endokrinologie - Universimed - Medizin im Fokus Management Diabetes mellitus Typ 1 – Consensus Report von ADA/EASD - Diabetologie & Endokrinologie - Universimed - Medizin im Fokus](https://www.universimed.com/__image/a/278286/alias/xxxl/v/2/c/13/ar/1-1/fn/AdobeStock_314731025.jpg)
Management Diabetes mellitus Typ 1 – Consensus Report von ADA/EASD - Diabetologie & Endokrinologie - Universimed - Medizin im Fokus
![Deviations from the ADA/EASD treatment algorithm is associated with higher cardiovascular events and death in type 2 diabetes under routine care - Media Centre | EASD Deviations from the ADA/EASD treatment algorithm is associated with higher cardiovascular events and death in type 2 diabetes under routine care - Media Centre | EASD](https://d2t0unnjxes6lt.cloudfront.net/data/easd/data/talks/1167_879989/Slide3.jpg)
Deviations from the ADA/EASD treatment algorithm is associated with higher cardiovascular events and death in type 2 diabetes under routine care - Media Centre | EASD
![Diabetes Typ-2 personalisiert behandeln! Paradigmenwechsel in der gemeinsamen Therapie-Leitlinie 2018 der Amerikanischen (ADA) und Europäischen (EASD) Diabetesgesellschaft | DGE Blog Diabetes Typ-2 personalisiert behandeln! Paradigmenwechsel in der gemeinsamen Therapie-Leitlinie 2018 der Amerikanischen (ADA) und Europäischen (EASD) Diabetesgesellschaft | DGE Blog](https://blog.endokrinologie.net/wp-content/uploads/2018/11/ADA-EASD-Guidelines-2018-2.jpg)
Diabetes Typ-2 personalisiert behandeln! Paradigmenwechsel in der gemeinsamen Therapie-Leitlinie 2018 der Amerikanischen (ADA) und Europäischen (EASD) Diabetesgesellschaft | DGE Blog
![2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00125-019-05039-w/MediaObjects/125_2019_5039_Fig1_HTML.png)
2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia
![Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00125-022-05787-2/MediaObjects/125_2022_5787_Fig3_HTML.png)